2006
DOI: 10.1097/01.meg.0000219104.40435.43
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study

Abstract: Our data suggest that neither single nor repeated determinations of GEC and MEGX are superior to CTP and MELD scores in predicting prognosis of patients with viral cirrhosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
16
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 33 publications
0
16
0
1
Order By: Relevance
“…MEGX is superior to prothrombin time and bilirubin measurement, and patients with a MEGX 15 or 30 min test value <10 μg/L have a poor 1-year survival rate. MEGX is, however, inferior to Child–Pugh class and MELD score in predicting prognosis of patients with cirrhosis,31 but one study found reduction in MEGX concentration to correlate well with histological worsening of cirrhosis 32…”
Section: Quantitative Tests Of Hepatic Functionmentioning
confidence: 99%
“…MEGX is superior to prothrombin time and bilirubin measurement, and patients with a MEGX 15 or 30 min test value <10 μg/L have a poor 1-year survival rate. MEGX is, however, inferior to Child–Pugh class and MELD score in predicting prognosis of patients with cirrhosis,31 but one study found reduction in MEGX concentration to correlate well with histological worsening of cirrhosis 32…”
Section: Quantitative Tests Of Hepatic Functionmentioning
confidence: 99%
“…[4][5][6] However, neither scoring system is suitable to predict mortality after liver transplantation. Thus, given the known importance of the donor in any transplant setting, but particularly in liver transplantation, it is reasonable-and we believe ethically correct-to consider liver transplantation outcomes when deciding who is to be transplanted.…”
mentioning
confidence: 99%
“…Furthermore, MBT reliably distinguishes between early cirrhotic (Child-Pugh Class A) and non-cirrhotic patients [22]. Other metabolic tests have also been shown to complement the MELD and Child-Pugh scores in predicting complications and death from cirrhosis, such as the galactose elimination capacity and the monoethylglycinexylidide (MEGX) test over a period of six months [23,24], but these tests are cumbersome and not suitable for point-of-care testing.…”
Section: Discussionmentioning
confidence: 98%